Literature DB >> 33476084

Alternative methods of viability determination in single cell mass cytometry.

Raymond D Devine1, Hussam S Alkhalaileh1, Justin M Lyberger1, Gregory K Behbehani1.   

Abstract

The identification and discrimination of viable cells is important to understand how experimental variables may influence biochemical processes such as cell metabolism, cell cycle, and signaling pathways. Cisplatin is commonly used as a viability stain in mass cytometry studies, however, recent work by Mei et al. has demonstrated that cisplatin can also be used to label antibodies, complicating the simultaneous use of the platinum measurement channels for both antibody and viability staining. This study demonstrates that other metal salts (hafnium chloride, niobium chloride, and zirconium chloride) can serve as substitutes for cisplatin in viability staining. These stains yield similar fractions of live and dead cells and stain the same dead cells in parallel high parameter analyses. In addition, this study demonstrates how a variety of protein antigen viability markers (pRb, Ki-67, Histone H1, cleaved PARP, and GAPDH) can be used to discriminate live and dead cell populations, without the need for a sperate viability staining step. As few as two of these protein antigen viability markers can help identify live and dead cell populations in fixed samples and can identify the same viable cells in high dimensional analyses with or without use of viability stain information. This study demonstrates several alternative approaches to mass cytometry viability assessment that can facilitate use of platinum isotopes for antibody staining and enables identification of live and dead cell populations in samples for which a separate viability stain is not practical. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Mass cytometry; cell death; cell viability; chemotherapy; cisplatin

Year:  2021        PMID: 33476084     DOI: 10.1002/cyto.a.24308

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  2 in total

1.  Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV.

Authors:  Meisam Naeimi Kararoudi; Shibi Likhite; Ezgi Elmas; Kenta Yamamoto; Maura Schwartz; Kinnari Sorathia; Marcelo de Souza Fernandes Pereira; Yasemin Sezgin; Raymond D Devine; Justin M Lyberger; Gregory K Behbehani; Nitin Chakravarti; Branden S Moriarity; Kathrin Meyer; Dean A Lee
Journal:  Cell Rep Methods       Date:  2022-06-13

2.  Cisplatin Uptake in Macrophage Subtypes at the Single-Cell Level by LA-ICP-TOFMS Imaging.

Authors:  Anna Schoeberl; Michael Gutmann; Sarah Theiner; Martin Schaier; Andreas Schweikert; Walter Berger; Gunda Koellensperger
Journal:  Anal Chem       Date:  2021-11-30       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.